Alimera sciences to present at the h.c. wainwright 2nd annual ophthalmology virtual conference

Atlanta, aug. 10, 2022 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today that rick eiswirth, alimera's president and chief executive officer, will deliver a corporate presentation at the hc wainwright 2nd annual ophthalmology conference being held virtually on wednesday, august 17, 2022.
ALIM Ratings Summary
ALIM Quant Ranking